LOS ANGELES, July 25, 2023 - B. Riley Securities, Inc. ("B. Riley"), a leading middle market investment bank and subsidiary of B. Riley Financial, Inc. (Nasdaq: RILY), is pleased to have served as sole bookrunner to Harrow Health, Inc. ("Harrow") in its $69 million offering of common stock, upsized from a base of $35 million, following two days of confidential marketing.
Harrow Health, Inc. is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten branded FDA‑approved ophthalmic pharmaceutical products, in addition to ImprimisRx, a pharmaceutical compounding business, which also serves as a mail‑order pharmacy licensed to ship prescription medications in all 50 states. Learn more here.
A representative of Harrow stated, "We were very pleased with the entire process - and the successful outcome - of our recent transaction with B. Riley Securities as sole book-running manager. They were professional, organized and an excellent partner to help guide us through and deliver a successful equity financing transaction."
Mark Baum, CEO of Harrow, remarked: "As an executive in the public markets for nearly 25 years, disappointment in dealing with investment banking firms that overpromise and underdeliver is a far too common experience. That has not been the case with B. Riley, who has always delivered!"
B. Riley's Investment Banking coverage team was led by Patrice McNicoll, Matthew Feinberg and included Melissa Woodson, Daniel Lewis and Connor Boyle.
B. Riley's Capital Markets team was led by Jimmy Baker, Brian Taylor, Ryan Aceto and Dawn Farrell, and included Kathy Innis, Riley Slusarski and Sam Cook.
Read more about the transaction here.
About B. Riley Securities
B. Riley has served as a preeminent fixture in middle market brokerage and investment banking for over 25 years. We provide a full suite of investment banking and capital markets services to companies, financial sponsors, and institutional investors across all industry verticals. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. Widely recognized for our thematic proprietary equity research, clients benefit from B. Riley's extensive network, industry expertise, and proven execution capabilities of our end-to-end financial services platform. B. Riley Securities is a subsidiary of B. Riley Financial (Nasdaq: RILY). For more information, visit www.brileysecurities.com.